Prompt treatment of chlamydia and gonorrhea following a confirmed diagnosis is essential to prevent complications and reduce ...

A bill set to be considered during the upcoming legislative session would make it a crime to intentionally expose others to a ...

The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.

This study aimed to quantify the overall treatment rate for chlamydia and gonorrhea and identify factors associated with treatment delays and disparities.

In the UK, the number of sexually transmitted diseases that are difficult to treat with general antibiotics has increased ...

Only 14% of chlamydia cases were treated with the recommended doxycycline and only 38.7% of gonorrhea cases were treated with the recommended ceftriaxone. Women, young adults (ages 10-29), and ...

The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and trichomoniasis in females. The so-called Visby Medical Women's Sexual Health Test ...

The US Food and Drug Administration (FDA) has granted marketing authorization for the first at-home test to diagnose ...

While there’s been a slight dip in STD rates across the country, the South continues to see infection levels that raise ...

Background and goal: Prompt treatment of chlamydia and gonorrhea following a confirmed diagnosis is essential to prevent complications and reduce transmission. Adherence to the Centers for Disease ...